Generic Drugs: Afatinib EGFR Inhibitor NSCLC

So, afatinib is this drug that blocks two specific parts of a protein in lung cancer patients who have certain changes in their EGFR gene. It stops something called EGFR signaling in its tracks.

Afatinib is available in 20 mg, 30 mg, and 40 mg film-coated tablets, with the recommended dose being 40 mg once daily on an empty stomach. Each pack has 30 tablets, all in a bottle.